Pharmacological management of erectile dysfunction

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

Crynodeb

Erectile dysfunction is a common sexual dysfunction, with an estimated prevalence of 8% among men aged 40 years and 40% among men aged 60 years. It is associated with cardiovascular risk factors. Treatment is commonly with ‘as required’ or daily phosphodiesterase type 5 inhibitors: sildenafil citrate, tadalafil, or vardenafil, although other options are available. The selection of treatment is dependent on accurate assessment, estimation of cardiovascular risk, and patient choice. In this article, treatment choices are considered and strategies for optimizing treatment are recommended.
Iaith wreiddiolSaesneg
Tudalennau (o-i)339-344
CyfnodolynNurse Prescribing
Cyfrol10
Rhif cyhoeddi7
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 1 Gorff 2012
Cyhoeddwyd yn allanolIe

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Pharmacological management of erectile dysfunction'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn